Changing spectrum of the diffuse infiltrative lymphocytosis syndrome

Dhiman Basu, Francis M. Williams, Chul W. Ahn, John D. Reveille

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

Objective. To describe the changing clinical spectrum of patients with diffuse infiltrative lymphocytosis syndrome (DILS) after the introduction of highly active antiretroviral treatment (HAART), and to carry out HLA class II oligotyping in these patients. Methods. A retrospective chart review of patients with DILS who were referred to an outpatient facility for human immunodeficiency virus (HIV)-positive individuals between 1994 and 2003 was performed. DILS was diagnosed as suggested by previous criteria. Demographic features and relevant clinical, laboratory, and radiologic data were recorded and results analyzed. Results. A total of 129 patients with DILS were identified. Of them, 56 (43%) were African American, 41 (32%) were white, and 32 (25%) were Hispanic. Parotid gland swelling appeared to be the sine qua non of DILS. Twenty-seven percent of patients had opportunistic infections. The status of 103 patients was available as of December 2003: 26 (25%) had died, of which only 6 (6%) succumbed to opportunistic infections. The prevalence of DILS had significantly decreased in the post-HAART era (1998 onwards) compared with that of the pre-HAART period (P < 0.000001). The prevalence of lymphocytic interstitial pneumonitis had also dropped significantly following introduction of HAART therapy (P = 0.015). A higher frequency of certain HLA class II alleles (DRB1) was found in African Americans with DILS compared with those with HIV without DILS (P = 0.008). Conclusion. The epidemiology, clinical presentation, and certain extraglandular manifestations of DILS have changed, concomitant with the introduction of HAART, further suggesting that DILS is an antigen (viral)-driven response and the primary treatment for it is anti-HIV therapy.

Original languageEnglish (US)
Pages (from-to)466-472
Number of pages7
JournalArthritis Care and Research
Volume55
Issue number3
DOIs
StatePublished - Jun 15 2006

Fingerprint

Lymphocytosis
Opportunistic Infections
HIV
African Americans
Therapeutics
Viral Antigens
Parotid Gland
Interstitial Lung Diseases
Highly Active Antiretroviral Therapy
Hispanic Americans
Epidemiology
Outpatients
Alleles
Demography

Keywords

  • HAART
  • HIV infection
  • Parotid enlargement
  • Sjögren's syndrome

ASJC Scopus subject areas

  • Rheumatology

Cite this

Changing spectrum of the diffuse infiltrative lymphocytosis syndrome. / Basu, Dhiman; Williams, Francis M.; Ahn, Chul W.; Reveille, John D.

In: Arthritis Care and Research, Vol. 55, No. 3, 15.06.2006, p. 466-472.

Research output: Contribution to journalArticle

Basu, Dhiman ; Williams, Francis M. ; Ahn, Chul W. ; Reveille, John D. / Changing spectrum of the diffuse infiltrative lymphocytosis syndrome. In: Arthritis Care and Research. 2006 ; Vol. 55, No. 3. pp. 466-472.
@article{e3e26108e7af4450b985ad71efec2ccb,
title = "Changing spectrum of the diffuse infiltrative lymphocytosis syndrome",
abstract = "Objective. To describe the changing clinical spectrum of patients with diffuse infiltrative lymphocytosis syndrome (DILS) after the introduction of highly active antiretroviral treatment (HAART), and to carry out HLA class II oligotyping in these patients. Methods. A retrospective chart review of patients with DILS who were referred to an outpatient facility for human immunodeficiency virus (HIV)-positive individuals between 1994 and 2003 was performed. DILS was diagnosed as suggested by previous criteria. Demographic features and relevant clinical, laboratory, and radiologic data were recorded and results analyzed. Results. A total of 129 patients with DILS were identified. Of them, 56 (43{\%}) were African American, 41 (32{\%}) were white, and 32 (25{\%}) were Hispanic. Parotid gland swelling appeared to be the sine qua non of DILS. Twenty-seven percent of patients had opportunistic infections. The status of 103 patients was available as of December 2003: 26 (25{\%}) had died, of which only 6 (6{\%}) succumbed to opportunistic infections. The prevalence of DILS had significantly decreased in the post-HAART era (1998 onwards) compared with that of the pre-HAART period (P < 0.000001). The prevalence of lymphocytic interstitial pneumonitis had also dropped significantly following introduction of HAART therapy (P = 0.015). A higher frequency of certain HLA class II alleles (DRB1) was found in African Americans with DILS compared with those with HIV without DILS (P = 0.008). Conclusion. The epidemiology, clinical presentation, and certain extraglandular manifestations of DILS have changed, concomitant with the introduction of HAART, further suggesting that DILS is an antigen (viral)-driven response and the primary treatment for it is anti-HIV therapy.",
keywords = "HAART, HIV infection, Parotid enlargement, Sj{\"o}gren's syndrome",
author = "Dhiman Basu and Williams, {Francis M.} and Ahn, {Chul W.} and Reveille, {John D.}",
year = "2006",
month = "6",
day = "15",
doi = "10.1002/art.21980",
language = "English (US)",
volume = "55",
pages = "466--472",
journal = "Arthritis and Rheumatology",
issn = "2326-5191",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

TY - JOUR

T1 - Changing spectrum of the diffuse infiltrative lymphocytosis syndrome

AU - Basu, Dhiman

AU - Williams, Francis M.

AU - Ahn, Chul W.

AU - Reveille, John D.

PY - 2006/6/15

Y1 - 2006/6/15

N2 - Objective. To describe the changing clinical spectrum of patients with diffuse infiltrative lymphocytosis syndrome (DILS) after the introduction of highly active antiretroviral treatment (HAART), and to carry out HLA class II oligotyping in these patients. Methods. A retrospective chart review of patients with DILS who were referred to an outpatient facility for human immunodeficiency virus (HIV)-positive individuals between 1994 and 2003 was performed. DILS was diagnosed as suggested by previous criteria. Demographic features and relevant clinical, laboratory, and radiologic data were recorded and results analyzed. Results. A total of 129 patients with DILS were identified. Of them, 56 (43%) were African American, 41 (32%) were white, and 32 (25%) were Hispanic. Parotid gland swelling appeared to be the sine qua non of DILS. Twenty-seven percent of patients had opportunistic infections. The status of 103 patients was available as of December 2003: 26 (25%) had died, of which only 6 (6%) succumbed to opportunistic infections. The prevalence of DILS had significantly decreased in the post-HAART era (1998 onwards) compared with that of the pre-HAART period (P < 0.000001). The prevalence of lymphocytic interstitial pneumonitis had also dropped significantly following introduction of HAART therapy (P = 0.015). A higher frequency of certain HLA class II alleles (DRB1) was found in African Americans with DILS compared with those with HIV without DILS (P = 0.008). Conclusion. The epidemiology, clinical presentation, and certain extraglandular manifestations of DILS have changed, concomitant with the introduction of HAART, further suggesting that DILS is an antigen (viral)-driven response and the primary treatment for it is anti-HIV therapy.

AB - Objective. To describe the changing clinical spectrum of patients with diffuse infiltrative lymphocytosis syndrome (DILS) after the introduction of highly active antiretroviral treatment (HAART), and to carry out HLA class II oligotyping in these patients. Methods. A retrospective chart review of patients with DILS who were referred to an outpatient facility for human immunodeficiency virus (HIV)-positive individuals between 1994 and 2003 was performed. DILS was diagnosed as suggested by previous criteria. Demographic features and relevant clinical, laboratory, and radiologic data were recorded and results analyzed. Results. A total of 129 patients with DILS were identified. Of them, 56 (43%) were African American, 41 (32%) were white, and 32 (25%) were Hispanic. Parotid gland swelling appeared to be the sine qua non of DILS. Twenty-seven percent of patients had opportunistic infections. The status of 103 patients was available as of December 2003: 26 (25%) had died, of which only 6 (6%) succumbed to opportunistic infections. The prevalence of DILS had significantly decreased in the post-HAART era (1998 onwards) compared with that of the pre-HAART period (P < 0.000001). The prevalence of lymphocytic interstitial pneumonitis had also dropped significantly following introduction of HAART therapy (P = 0.015). A higher frequency of certain HLA class II alleles (DRB1) was found in African Americans with DILS compared with those with HIV without DILS (P = 0.008). Conclusion. The epidemiology, clinical presentation, and certain extraglandular manifestations of DILS have changed, concomitant with the introduction of HAART, further suggesting that DILS is an antigen (viral)-driven response and the primary treatment for it is anti-HIV therapy.

KW - HAART

KW - HIV infection

KW - Parotid enlargement

KW - Sjögren's syndrome

UR - http://www.scopus.com/inward/record.url?scp=33745063671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745063671&partnerID=8YFLogxK

U2 - 10.1002/art.21980

DO - 10.1002/art.21980

M3 - Article

C2 - 16739215

AN - SCOPUS:33745063671

VL - 55

SP - 466

EP - 472

JO - Arthritis and Rheumatology

JF - Arthritis and Rheumatology

SN - 2326-5191

IS - 3

ER -